Clinical
RSSArticles
-
Treating Subclinical Hypothyroidism in Seniors
Since subclinical hypothyroidism often is a stepping stone to overt hypothyroidism, it is tempting to offer treatment for it. But does treatment of subclinical hypothyroidism improve outcomes?
-
FDA Actions
In this section: FDA approves new treatments for breast cancer and hepatitis C.
-
Study: Idarucizumab Safely Reverses Anticoagulant Effect of Dabigatran
Promising evidence emerges about the efficacy of the first reversal agent for one of the non-vitamin K oral anticoagulants.
-
How Long Should Patients Take Antibiotics?
Researchers from the United Kingdom proclaim 'the antibiotic course has had its day.'
-
Using Tramadol to Treat Opioid Withdrawal
The authors of a recent study found that the use of tramadol to treat opioid withdrawal symptoms was associated with fewer withdrawal symptoms compared to clonidine and was comparable to buprenorphine.
-
Federal Regulators Address Opioid Crisis
FDA says reducing the scope of the epidemic of opioid addiction is the agency's highest immediate priority.
-
Report: 92 Million American Adults Used Prescription Opioids in 2015
Of those, 11.5 million people misused opioids, and nearly 2 million adults suffered from an opioid use disorder.
-
Atrial Flutter or Atrial Tachycardia?
-
Clinical Briefs
In this section: nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding; rheumatoid arthritis; and community-acquired pneumonia.
-
Delafloxacin Tablets (Baxdela)
Delafloxacin is indicated for the treatment of acute bacterial skin and skin structure infections caused by susceptible organisms.